Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) begins to suppress appetite within the first week of starting treatment for many people, though the degree of that effect builds gradually over the titration schedule as your dose increases. Most people notice reduced hunger and earlier feelings of fullness within one to four weeks of their first injection. That timeline varies, and understanding what shapes it can help you set realistic expectations before you make any decision about whether this treatment is right for you. Like all prescription-only medicines, Mounjaro requires a clinical assessment before a prescriber decides whether it is appropriate for you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
When people ask how quickly Mounjaro suppresses appetite, they are usually at one of two points. Either they have just started and are waiting to feel something, or they are a few weeks in and wondering whether what they feel is normal. Both are reasonable places to be.
The honest answer is that 2.5mg (the starting dose) is a tolerability dose. Its job is to let your body adjust to the medicine, not to deliver the full appetite-reducing effect you might eventually experience at 10mg or 15mg. So if the first four weeks feel subtle, that is by design. The appetite effect tends to arrive in stages, tracking the titration schedule your prescriber has set.
By the time most people reach 5mg or 7.5mg, the shift is usually clearer: hunger signals arrive later in the day, portions feel satisfying at a smaller size, and the urge to snack often fades. The SURMOUNT-1 trial, published in the New England Journal of Medicine, found average body-weight reductions of around 20–21% at the 15mg dose over 72 weeks, that scale of change does not happen without meaningful appetite change, and participants did not all feel it on day one. If you are wondering how long it takes for Mounjaro to suppress appetite and what a typical progression looks like week by week, that question is covered in detail alongside the broader picture of how quickly Mounjaro works across different outcomes.
Several factors shape your personal timeline. None of them are character flaws, and most of them are simply biology.
Gastric emptying rate is one. Tirzepatide slows the movement of food from the stomach into the small intestine, which extends the physical sensation of fullness. People whose stomachs empty quickly at baseline may notice a more pronounced early shift; others experience a subtler change initially. Gut sensitivity also plays a role, the same mechanism that creates fullness can produce nausea in some people, particularly after dose increases, and when that happens the appetite effect and the nausea can feel intertwined rather than separate.
Dose level matters considerably. The timeline for appetite suppression to become consistent is generally linked to how far along the titration you are, not just how many days have passed since injection one. Eating habits also have an effect: people who habitually eat quickly or whose hunger is strongly driven by habit or emotion sometimes find the physiological signal from tirzepatide takes longer to override those patterns.
The NHS tirzepatide page notes that nausea and digestive effects are most common after starting or increasing a dose, and this is the same mechanism through which appetite is regulated, so side effects and therapeutic effects share a root.
Some people reach weeks six or eight and feel the suppression has plateaued or even dipped. This is worth understanding rather than worrying about.
The appetite signal from tirzepatide is partly dose-dependent. If you are still on a lower dose and have not yet titrated, the effect you currently feel may be close to the ceiling for that dose. It is not a sign the medicine has stopped working. If appetite suppression seems absent, a conversation with your prescriber (rather than a change made independently) is the right move.
There is also a psychological adjustment period. After a few weeks, reduced hunger can start to feel like the new baseline, and people sometimes interpret that as the effect wearing off when actually it has simply become normal. Keeping a brief record of appetite and portion size during the first couple of months can help you and your prescriber see the actual trend clearly.
For context on the cost of private treatment while you weigh up your options, the Mounjaro pricing page sets out what a transparent private prescription typically includes in the UK.
Because the appetite effect builds across the titration schedule, the clinical relationship matters more than most people expect before they start. A prescriber does not simply issue a prescription and step back. At num, a real clinician reviews your consultation and, before each repeat, looks at how you are responding, hunger levels, tolerability, any side effects, and whether a dose change is appropriate.
If you order before midday on a working day and your consultation is clinically approved, your treatment is dispatched the same day. It is that kind of rhythm (your pen ready in the fridge before the week starts, rather than waiting) that makes it easier to stay on the titration schedule where the appetite effect is strongest.
If you are still weighing up whether to start, you might find it useful to read about how long Mounjaro takes to work in terms of weight change, or to explore our weight-loss treatment options more broadly. Our clinical team reviews every consultation personally. When you are ready to take the next step, speak to our prescribers through a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.